Editorial for “Development and Validation of a Deep Learning System to Differentiate HER2‐Zero, HER2‐Low, and HER2‐Positive Breast Cancer Based on Dynamic Contrast‐Enhanced MRI”
- 8 January 2025
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (5) , 2221-2222
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Development and Validation of a Deep Learning System to Differentiate HER2‐Zero, HER2‐Low, and HER2‐Positive Breast Cancer Based on Dynamic Contrast‐Enhanced MRIJournal of Magnetic Resonance Imaging, 2024
- Multitask Deep Learning‐Based Whole‐Process System for Automatic Diagnosis of Breast Lesions and Axillary Lymph Node Metastasis Discrimination from Dynamic Contrast‐Enhanced‐MRI: A Multicenter StudyJournal of Magnetic Resonance Imaging, 2023
- The 50-Year War on Cancer Revisited: Should We Continue to Fight the Enemy Within?Journal of Cancer Prevention, 2021
- The Changing Paradigm for the Treatment of HER2-Positive Breast CancerCancers, 2020
- The causes and consequences of genetic heterogeneity in cancer evolutionNature, 2013
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012